Summary In November 2021, Omicron BA. 1, containing a raft of new spike mutations,
emerged and quickly spread globally. Intense selection pressure to escape the antibody …

SARS-CoV-2 Omicron variant has presented significant challenges to current antibodies
and vaccines. Herein, we systematically compared the efficacy of 50 human monoclonal …

The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA. 1 …

Emerging Omicron sub-variants are causing global concerns, and their immune evasion
should be monitored continuously. We previously evaluated the escape of Omicron BA. 1 …

The Omicron BA. 1 variant of SARS-CoV-2 escapes convalescent sera and monoclonal
antibodies that are effective against earlier strains of the virus. This immune evasion is …

Summary SARS-CoV-2 Omicron BA. 2.75 has diversified into multiple subvariants with
additional spike mutations and several are expanding in prevalence, particularly CH. 1.1 …

In recent months, additional Omicron variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), including the BA. 5 sublineage BF. 7 and BQ. 1.1 and the BA …

Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here, we
compare neutralization of Omicron BA. 1, BA. 1.1, and BA. 2. BA. 2 RBD has slightly higher …

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6 | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Summary The SARS-CoV-2 Omicron variant has evolved into four sub-lineages—BA. 1, BA.
1.1, BA. 2, and BA. 3—with BA. 2 becoming dominant worldwide. We and others have …